Satellos Bioscience Inc. (TSX:MSCL)
Canada
· Delayed Price · Currency is CAD 16.20
-0.76 (-4.48%)
Mar 6, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 334.16 million as of March 6, 2026. Its market cap has increased by 168.68% in one year.
Market Cap
334.16M
Enterprise Value
285.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
16.20
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 334.16M, an increase of 467.99%. That is a compound annual growth rate of 46.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 349.83M | 185.73% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NervGen Pharma | 440.46M |
| Eupraxia Pharmaceuticals | 649.36M |
| Helix BioPharma | 156.58M |
| Bright Minds Biosciences | 1.06B |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 74.24M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 56.27M |